Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    First Wave BioPharma Inc.

    NASDAQ: FWBI · Real-Time Price · USD
    2.96
    0.13 (4.59%)
    At close: May 16, 2024, 10:00 PM

    First Wave BioPharma Statistics

    Share Statistics

    First Wave BioPharma has 2.03M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 2.03M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 2.34M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,631

    FTD / Avg. Volume

    n/a
    		 2.25%

    Short Selling Information

    The latest short interest is 53.54K, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 53.54K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 1.49

    Valuation Ratios

    The PE ratio is -0.39 and the forward PE ratio is null. First Wave BioPharma's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.39

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 -1.83

    P/FCF Ratio

    n/a
    		 -0.77

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for First Wave BioPharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.03, with a Debt / Equity ratio of -0.04.

    Current Ratio

    n/a
    		 3.03

    Quick Ratio

    n/a
    		 3.03

    Debt / Equity

    n/a
    		 -0.04

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.02

    Interest Coverage

    n/a
    		 -17852.88

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-2,006,592.89

    Employee Count

    n/a
    		 9

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 43% in the last 52 weeks. The beta is 1.28, so First Wave BioPharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.28

    52-Week Price Change

    n/a
    		 43%

    50-Day Moving Average

    n/a
    		 2.82

    200-Day Moving Average

    n/a
    		 4.96

    Relative Strength Index (RSI)

    n/a
    		 30.29

    Average Volume (20 Days)

    n/a
    		 72,481

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -15.62M

    Net Income

    n/a
    		 -18.06M

    EBITDA

    n/a
    		 -15.62M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -5.33
    Full Income Statement

    Balance Sheet

    The company has 163.48K in cash and 140.53K in debt, giving a net cash position of 22.94K.

    Cash & Cash Equivalents

    n/a
    		 163.48K

    Total Debt

    n/a
    		 140.53K

    Net Cash

    n/a
    		 22.94K

    Retained Earnings

    n/a
    		 -202.39M

    Total Assets

    n/a
    		 85.2M

    Working Capital

    n/a
    		 54.72M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -9.22M and capital expenditures 0, giving a free cash flow of -9.22M.

    Operating Cash Flow

    n/a
    		 -9.22M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -9.22M

    FCF Per Share

    n/a
    		 -2.68
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    FWBI does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for FWBI.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Dec 18, 2023. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Dec 18, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -2.74

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist